An assessment of the ability of insulin-stimulated cyclic AMP phosphodiesterase to decrease hepatocyte intracellular...

Area of Science:

• Biochemistry
• Cell Biology
• Hormone Signaling

Background:

• Insulin and glucagon are key hormones regulating glucose metabolism and intracellular cyclic AMP (cAMP) levels in hepatocytes.
• Cyclic AMP phosphodiesterases (PDEs) are enzymes that hydrolyze cAMP, influencing cellular signaling pathways.
• The specific PDE isoforms involved in insulin's regulation of cAMP remain incompletely understood.

Purpose of the Study:

• To investigate the role of the 'dense-vesicle' cyclic AMP phosphodiesterase in insulin's action.
• To determine the contribution of the plasma-membrane cyclic AMP phosphodiesterase to insulin's effect on intracellular cAMP levels.
• To elucidate the mechanisms by which insulin modulates cAMP concentrations in hepatocytes, particularly in the context of glucagon stimulation.

Main Methods:

• Hepatocytes were treated with agents like ammonium chloride (NH4Cl) or fructose to inhibit specific PDE activities.
• Insulin's effect on intracellular cAMP levels was measured in the presence and absence of glucagon and inhibitors.
• The activity of plasma-membrane and 'dense-vesicle' cyclic AMP phosphodiesterases was assessed under various experimental conditions.

Main Results:

• Inhibition of the 'dense-vesicle' cyclic AMP phosphodiesterase with NH4Cl or fructose did not block insulin's ability to lower glucagon-induced cAMP levels.
• Insulin treatment was found to activate the plasma-membrane cyclic AMP phosphodiesterase.
• Blocking glucagon's inhibitory effect on plasma-membrane PDE activity potentiated insulin's action to reduce elevated cAMP levels.

Conclusions:

• The 'dense-vesicle' cyclic AMP phosphodiesterase is not significantly involved in insulin's regulation of intracellular cAMP levels in hepatocytes.
• Insulin primarily exerts its effect by activating the plasma-membrane cyclic AMP phosphodiesterase.
• Activation of the plasma-membrane PDE by insulin is a crucial mechanism for reducing elevated intracellular cAMP concentrations, impacting metabolic regulation.